Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Omar Akil

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Hearing Research|February 19, 2020
Dual and triple AAV delivery of large therapeutic gene sequences into the inner earOmar Akil
Methods in Molecular Biology (Clifton, N.J.)|February 21, 2019
AAV-Mediated Gene Delivery to the Inner EarOmar Akil, Lawrence Lustig
Cold Spring Harbor Perspectives in Medicine|October 17, 2018
Cochlear Gene TherapyLawrence Lustig, Omar Akil
Bio-Protocol|August 23, 2016
Mouse Cochlear Whole Mount ImmunofluorescenceOmar Akil, Lawrence R Lustig
Neuroscience Research|February 14, 2012
Severe vestibular dysfunction and altered vestibular innervation in mice lacking prosaposinOmar Akil, Lawrence R Lustig
Current Opinion in Neurology|December 14, 2011
Cochlear gene therapyLawrence R Lustig, Omar Akil
Hearing Research|April 26, 2020
Neurotrophin gene therapy to promote survival of spiral ganglion neurons after deafnessPatricia A Leake, Omar Akil, Hainan Lang
Bio-Protocol|March 11, 2017
Mouse Auditory Brainstem Response TestingOmar Akil, A E Oursler, Kevin Fan, et al.
Journal of the Association for Research in Otolaryngology : JARO|June 22, 2019
AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNFPatricia A Leake, Stephen J Rebscher, Chantale Dore', et al.
Human Gene Therapy|September 6, 2018
Virally Mediated Overexpression of Glial-Derived Neurotrophic Factor Elicits Age- and Dose-Dependent Neuronal Toxicity and Hearing LossOmar Akil, Bas Blits, Lawrence R Lustig, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Hearing Research|February 19, 2020
Dual and triple AAV delivery of large therapeutic gene sequences into the inner earOmar Akil
Methods in Molecular Biology (Clifton, N.J.)|February 21, 2019
AAV-Mediated Gene Delivery to the Inner EarOmar Akil, Lawrence Lustig
Cold Spring Harbor Perspectives in Medicine|October 17, 2018
Cochlear Gene TherapyLawrence Lustig, Omar Akil
Bio-Protocol|August 23, 2016
Mouse Cochlear Whole Mount ImmunofluorescenceOmar Akil, Lawrence R Lustig
Neuroscience Research|February 14, 2012
Severe vestibular dysfunction and altered vestibular innervation in mice lacking prosaposinOmar Akil, Lawrence R Lustig
Current Opinion in Neurology|December 14, 2011
Cochlear gene therapyLawrence R Lustig, Omar Akil
Hearing Research|April 26, 2020
Neurotrophin gene therapy to promote survival of spiral ganglion neurons after deafnessPatricia A Leake, Omar Akil, Hainan Lang
Bio-Protocol|March 11, 2017
Mouse Auditory Brainstem Response TestingOmar Akil, A E Oursler, Kevin Fan, et al.
Journal of the Association for Research in Otolaryngology : JARO|June 22, 2019
AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNFPatricia A Leake, Stephen J Rebscher, Chantale Dore', et al.
Human Gene Therapy|September 6, 2018
Virally Mediated Overexpression of Glial-Derived Neurotrophic Factor Elicits Age- and Dose-Dependent Neuronal Toxicity and Hearing LossOmar Akil, Bas Blits, Lawrence R Lustig, et al.
Pageof 4